These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

176 related articles for article (PubMed ID: 4169706)

  • 41. Administration of measles-mumps-rubella vaccination with other childhood schedule vaccines.
    Heath TC; Burgess MA; O'Brien ED
    Commun Dis Intell; 1998 Aug; 22(8):159. PubMed ID: 9735551
    [No Abstract]   [Full Text] [Related]  

  • 42. Effect of simultaneous administration of live measles vaccine on the "take rate" of live mumps vaccine.
    André FE; Peetermans J
    Dev Biol Stand; 1986; 65():101-7. PubMed ID: 3556770
    [TBL] [Abstract][Full Text] [Related]  

  • 43. Antibody responses in serum and nasal secretions of children immunized with inactivated and attenuated measles-virus vaccines.
    Bellanti JA; Sanga RL; Klutinis B; Brandt B; Artenstein MS
    N Engl J Med; 1969 Mar; 280(12):628-33. PubMed ID: 4179401
    [No Abstract]   [Full Text] [Related]  

  • 44. [Certain problems with limits of immunity against measles, mumps and rubella].
    Magdzik W
    Przegl Epidemiol; 1993; 47(1-2):47-53. PubMed ID: 8351387
    [TBL] [Abstract][Full Text] [Related]  

  • 45. Immune responses of mentally retarded subjects to measles, mumps and rubella vaccines.
    Sinha SK; Carlson SD
    Wis Med J; 1975 Jul; 74(7):75-7. PubMed ID: 1163054
    [No Abstract]   [Full Text] [Related]  

  • 46. [Mumps-antibody formation in guinea pigs following a single virus application. Evaluation of live mumps-virus vaccine].
    Gladthe H; Abel C
    J Hyg Epidemiol Microbiol Immunol; 1972; 16(2):202-7. PubMed ID: 5064723
    [No Abstract]   [Full Text] [Related]  

  • 47. [Field trial with a new human diploid cell vaccine (HDCV) against measles, mumps and rubella].
    Just M; Berger R; Glück R; Wegmann A
    Schweiz Med Wochenschr; 1985 Nov; 115(48):1727-30. PubMed ID: 4081704
    [TBL] [Abstract][Full Text] [Related]  

  • 48. [Development of measles vaccination in Austria].
    Huber EG; Rannon L
    Padiatr Padol; 1973; 8(3):247-56. PubMed ID: 4715034
    [No Abstract]   [Full Text] [Related]  

  • 49. Serological evaluation of 52 children immunized with the combined measles, mumps and rubella vaccine.
    Topal B; Kanra G; Ceyhan M
    Turk J Pediatr; 1991; 33(1):13-8. PubMed ID: 1844171
    [TBL] [Abstract][Full Text] [Related]  

  • 50. [Fever reaction and the effect on antibody formation of vaccination with commercially available KL measles vaccine, with special reference take-rate of live vaccine and need for additional immunization].
    Santo K; Tatsumi H; Kato K; Hanaya T; Abe S
    Nihon Shonika Gakkai Zasshi; 1969 Apr; 73(4):594-9. PubMed ID: 5817479
    [No Abstract]   [Full Text] [Related]  

  • 51. Measles immune globulin. Proposed standard dose given with liver attenuated measles virus vaccine.
    Warren RJ; Nader PR; Levine RH
    JAMA; 1968 Jan; 203(3):186-8. PubMed ID: 4169348
    [No Abstract]   [Full Text] [Related]  

  • 52. [Studies on the combined use of attenuated and live vaccines for measles. 1. Evaluation of vaccination with live vaccine after administration of the attenuated vaccine once or twice].
    Seki T
    Nihon Shonika Gakkai Zasshi; 1966 Dec; 70(12):1340-9. PubMed ID: 6010153
    [No Abstract]   [Full Text] [Related]  

  • 53. Jeryl Lynn Strain Live Attenuated Mumps Virus vaccine in a private pediatric practice.
    Nickey LN; Huchton P; McGee WG
    South Med J; 1970 Mar; 63(3):306-8. PubMed ID: 4905918
    [No Abstract]   [Full Text] [Related]  

  • 54. [Studies on the combined use of attenuated and live vaccines for measles. 2. Evaluation of vaccination with live vaccine after a long period following administration of the attenuated vaccine 2 or 3 times].
    Seki T
    Nihon Shonika Gakkai Zasshi; 1966 Dec; 70(12):1350-62. PubMed ID: 6010154
    [No Abstract]   [Full Text] [Related]  

  • 55. Use of attenuated live mumps virus vaccine during a "virgin soil" epidemic of mumps on St. Paul Island, Alaska.
    Maynard JE; Shramek G; Noble GR; Deinhardt F; Clark P
    Am J Epidemiol; 1970 Nov; 92(5):301-6. PubMed ID: 5473777
    [No Abstract]   [Full Text] [Related]  

  • 56. Jeryl Lynn strain live mumps virus vaccine. Durable immunity for three years following vaccination.
    Weibel RE; Buynak EB; Whitman JE; Leagus MB; Stokes J; Hilleman MR
    JAMA; 1969 Mar; 207(9):1667-70. PubMed ID: 5818350
    [No Abstract]   [Full Text] [Related]  

  • 57. Live vaccines against influenza, adenoviruses, measles, and mumps.
    Smorodintsev AA; Alexandrova GI; Boychuck LM; Nasibov MN; Selivanov AA; Taros LY
    Arch Environ Health; 1969 Jan; 18(1):105-14. PubMed ID: 4302157
    [No Abstract]   [Full Text] [Related]  

  • 58. KILLED MEASLES VACCINE PRIOR TO SEVEN MONTHS OF AGE FOLLOWED BY ATTENUATED LIVE VIRUS VACCINE AT NINE MONTHS.
    KARELITZ S; SCHLUEDERBERG A; KANCHANAVATEE P; ARAI M; ACS H
    Arch Gesamte Virusforsch; 1965; 16():343-6. PubMed ID: 14322891
    [No Abstract]   [Full Text] [Related]  

  • 59. [Evaluation of the vaccination of a misture of inactivated and live measles vaccines. 1. Clinicoserological observation for a period of 4 years].
    Tanaka H
    Nihon Shonika Gakkai Zasshi; 1972 Mar; 76(3):162-9. PubMed ID: 5065657
    [No Abstract]   [Full Text] [Related]  

  • 60. [Clinical and serological studies on live attenuated rubella virus vaccines used alone and in conjugation with measles vaccines].
    Tsuji A
    Kansenshogaku Zasshi; 1970 Mar; 43(12):394-408. PubMed ID: 4987126
    [No Abstract]   [Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 9.